PLGA nanospheres for the ocular delivery of flurbiprofen: Drug release and interactions

Journal of Pharmaceutical Sciences

Volumn 97, Issue 12, 2008, Pages 5306-5317

  Vega, E ^a   Gamisans, F ^a   Garcia M L ^a   Chauvet, A ^b   Lacoulonche, F ^c   Egea, M A ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

^b UNIV MONTPELLIER   (France)

^c Calytherm   (France)

Author keywords

Corneal permeation; DSC; Ocular drug delivery; Poly(D,L lactide co glycolide) nanospheres; Thermomicroscopy

Indexed keywords

EYE DROPS; FLURBIPROFEN; NANOSPHERE; OCUFLUR; POLOXAMER; POLYGLACTIN; RESOMER; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATOMIC FORCE MICROSCOPY; CONTROLLED STUDY; CORNEA; DRUG DELIVERY SYSTEM; DRUG DIFFUSION; DRUG FORMULATION; DRUG PENETRATION; DRUG RELEASE; DRUG SOLUBILITY; INFRARED SPECTROSCOPY; NONHUMAN; TRANSMISSION ELECTRON MICROSCOPY; X RAY DIFFRACTION;

EID: 57349134515     PISSN: 00223549     EISSN: 15206017     Source Type: Journal    
DOI: 10.1002/jps.21383     Document Type: Article

References (39)

1. Kreuter J. 1993. Particulates (nanoparticles and microparticles). In: Mitra AK, editor. Ophthalmic drug delivery systems. New York: Marcel Dekker. pp 275-285.
2. Giannavola C, Bucolo C, Maltese A, Paolino D, Vandelli MA, Puglisi G, Lee VHL, Fresta M. 2003. Influence of preparation conditions on acyclovir-loaded poly-d,l-Lactic acid nanospheres and effect of PEG coating on ocular drug bioavailability. Pharm Res 20:584-590.
3. Wise DL, Fellman TD, Sanderson JE, Wentworth RI. 1979. Lactide/glycolide acid polymers. In: Gregoriadis G, editor. Drug carriers in biology and medicine. London: Academic Press. pp 237-270.
4. Anderson JM, Shive MS. 1997. Biodegradation and biocompatibility of PLA and PLGA microspheres. Adv Drug Delivery Rev 28:5-24.
5. Deshpande AA, Heller J, Gurny R. 1998. Bioerodible polymers for ocular delivery. Crit Rev Ther Drug Carrier Syst 15:381-420.
6. Moghimi SM, Vega E, Garcia ML, Al-Hanbali OAR, Rutt KJ. 2006. Nanoparticulates as drug carriers. In: Torchilin VP, editor. Polymeric nanoparticles as drug carriers and controlled release implant devices. London: Imperial College Press. pp 29-42.
7. Van Sorge AA, Wijnen PH, van Delft JL, Carballosa Coré-Bodelier VMW, van Haeringer NJ. 1999. Flurbiprofen, S(R), eyedrops: Formulation, enantiomeric assay, shelflife and pharmacology. Pharm World Sci 21:91-95.
8. Lee VH-L, Robinson JR. 1979. Mechanistic and quantitative evaluation of precorneal pilocarpine disposition in albino rabbits. J Pharm Sci 68:678-684.
9. Patton TF, Robinson JR. 1976. Quantitative precorneal disposition of topically applied pilocarpine nitrate in rabbit eyes. J Pharm Sci 65:1295-1301.
10. Saettone MF. 2002. Progress and problems in ophthalmic drug delivery. Pharm Technol 131:167-171.
11. Lacoulonche F, Gamisans F, Chauvet A, García ML, Espina M, Egea MA. 1999. Stability and in vitro drug release of flurbiprofen-loaded poly-ecaprolactone nanospheres. Drug Dev Ind Pharm 25:983-993.
12. Pignatello R, Bucolo C, Spedalieri G, Maltese A, Puglisi G. 2002. Flurbiprofen-loaded acrylate polymer nanosuspensions for ophthalmic application. Biomaterials 23:3247-3255.
13. Vega E, Egea MA, Valls O, Espina M, García ML. 2006. Flurbiprofen loaded biodegradable nanoparticles for ophthalmic administration. J Pharm Sci 95:2393-2405.
14. Fessi H, Puisieux F, Devissaguet JP, Ammoury N, Benita S. 1989. Nanocapsule formation by interfacial polymer deposition following solvent displacement. Int J Pharm 55:R1-R4.
15. Albert KS, Raabe A, Garry M, Antal EJ, Gilespie WR. 1984. Determination of ibuprofen in capillary and venous plasma by high-performance liquid chromatography with ultraviolet detection. J Pharm Sci 73:1487-1489.
16. Panyam J, Williams D, Dash A, Leslie-Pelecky D, Labhasetwar V. 2004. Solid-state solubility influences encapsulation and release of hydrophobic drugs from PLGA/PLA nanoparticles. J Pharm Sci 93:1804-1814.
17. Gamisans F, Lacoulonche F, Chauvet A, Espina M, García ML, Egea MA. 1999. Flurbiprofen-loaded nanospheres: Analysis of the matrix structure by thermal methods. Int J Pharm 179:37-48.
18. Levy MY, Benita S. 1990. Drug release from submicronized o/w emulsion: A new in vitro kinetic evaluation model. Int J Pharm 66:29-37.
19. Thomas ML, Szeto VR, Gan CM, Polse KA. 1997. Sequential staining: The effects of sodium fluorescein, osmolality, and pH on human corneal epithelium. Optom Vision Sci 74:207-210.
20. Baeyens V, Varesio E, Veuthey J-L, Gurny R. 1997. Determination of dexamethasone in tears by capillary electrophoresis. J Chrom Biomed 692:222-226.
21. Schoenwald RD, Stewart P. 1980. Effect of particle size on ophthalmic bioavailability of dexamethasone suspensions in rabbits. J Pharm Sci 69:391-394.
22. Muller RH. 1991. Charge determinations. In: Muller RH, editor. Colloidal carriers for controlled drug delivery and targeting, modification, characterization and in vivo. Florida: CRC Press. pp 57-97.
23. Govender T, Stolnik S, Garnett MC, Illum L, Davis S. 1999. PLGA nanoparticles prepared by nanoprecipitation: Drug loading and release studies of a water soluble drug. J Control Release 57:171-185.
24. Ahlin P, Kristl J, Kristl A, Vrecer F. 2002. Investigation of polymeric nanoparticles as carriers of enaprilat for oral administration. Int J Pharm 239:113-120.
25. Dubernet C. 1995. Thermoanalysis of microspheres. Thermochim Acta 248:259-269.
26. Pignatello R, Amico D, Chiechio S, Spadaro C, Puglisi G, Giunchedi P. 2001. Preparation and analgesic activity of Eudragit RS1001 microparticles containing diflunisal. Drug Delivery 8:35-45.
27. Pignatello R, Ferro M, De Guidi G, Salemi G, Vendelli MA, Guccione S, Geppi M, Forte C, Puglisi G. 2001. Preparation, characterization and photosensivity studies of solid dispersions of diflunisal and Eudragit RS1001 and RL1001. Int J Pharm 218:27-42.
28. Chauvet A, Masse J. 1993. Interactions de substances psycotropes à l'état solide. II. étude des mélanges binaires méprobamate (I)-chlorydrate d'amitriptyline (I), méprobamate (I)-chlorydrate de clomipramine (I) et méprobamate (I)-chlorydrate de fluphénasine. Thermochim Acta 66:25-36.
29. Gref R, Minamitake Y, Peracchia MT, Trubetskoy V, Torchilin V, Langer R. 1994. Biodegradable long-circulating polymer nanospheres. Science 263:1600-1603.
30. Görner T, Gref R, Michenot D, Sommer F, Tran MN, Dellacherie E. 1999. Lidocaine-loaded biodegradable nanospheres I. Optimization of the drug incorporation into the polymer Matrix. J Control Release 57:259-268.
31. Polakovič M, Görner T, Gref R, Dellacherie E. 1999. Lidocaine loaded biodegradable nanospheres II. Modelling of drug release. J Control Release 60:169-177.
32. Chiarini A, Tartarini A, Fini A. 1984. pH solubility relationship and partition coefficients for some anti-inflammatory arylaliphatic acids. Arch Pharm 317:268-273.
33. Marchal-Heussler L, Fessi H, Devissaguet JP, Hoffman M, Maincent P. 1992. Colloidal drug delivery systems for the eye: A comparison of the efficacy of three different polymers: Polyisobutylcyanoacrylate; polylactic-co-glycolic acid; poly-epsilon-caprolacton. STP J Pharm Sci 2:98-104.
34. Calvo P, Thomas C, Alonso MJ, Vila Jato JL, Robinson J. 1994. Study of the mechanism of interaction of poly(ε-caprolactone) nanocapsules with the cornea by confocal laser scanning microscopy. Int J Pharm 103:283-291.
35. Gupta M, Majumdar DK. 1997. Effect of concentration, pH and preservative on in vitro transcorneal permeation of ibuprofen and flurbiprofen from non-buffered aqueous drops. Indian J Exp Biol 35:844-849.
36. Marsh RJ, Maurice DM. 1971. The influence of non-ionic detergents and other surfactants on human corneal permeability. Exp Eye Res 11:43-48.
37. Kaur IP, Smitha R. 2002. Penetration enhancers and ocular bioadhesives: Two new avenues for ophthalmic drug delivery. Drug Dev Ind Pharm 28:353-369.
38. Maurice DM, Riley MV. 1970. Ocular pharmacokinetics. In: Gragmore CN, editor. Biochemistry of the eye. London: Academic Press. pp 6-16.
39. Schoenwald RD, Huang H-S. 1983. Corneal penetration behaviour of β-blocking agents I: Physicochemical factors. J Pharm Sci 72:1266-1272.